Author name: Innoglide Pharma

Innoglide Pharmaceuticals Pvt. Ltd. has acquired Grysons Life Sciences to expand into the fast-growing pediatric and mother care segment.

RemeGen, a pioneering Chinese biopharmaceutical company, is drawing global attention with the advancement of its novel drug, Telitacicept, in the treatment of generalized myasthenia gravis (gMG). As FDA grants orphan drug status to Telitacicept for myasthenia gravis, this significant regulatory milestone highlights the drug’s potential in addressing a rare, debilitating autoimmune disorder. With promising clinical

The pharmaceutical industry is rapidly embracing a transformative era marked by Innovations in Smart Pharma Packaging: Enhancing Patient Engagement. At the PPL Conclave 2025, held on March 7 in Hyderabad, a high-impact panel discussion titled “Patient-Centric Packaging: Safe, Smart, Secure” shed light on the crucial intersection of packaging technology, patient well-being, and supply chain security.

The COVID-19 pandemic disrupted global supply chains, exposing vulnerabilities in pharmaceutical logistics and highlighting the need for greater efficiency, agility, and resilience. One transformative solution that has emerged as the new pillar of Indian pharma: Free Trade Warehousing Zones (FTWZs). These specially designated zones, designed for import and export-oriented warehousing and distribution, have witnessed a

OneSource Specialty Pharma’s Bengaluru Unit 2 achieves ANVISA GMP Certification, a major milestone that affirms the company’s adherence to world-class pharmaceutical manufacturing standards. This significant achievement, granted by ANVISA (Agência Nacional de Vigilância Sanitária) — Brazil’s National Health Surveillance Agency — empowers OneSource to expand its global footprint, especially in regulated markets across Latin America.

Cadila Pharmaceuticals has recently introduced Vasograin EC, an advanced formulation designed to provide effective relief from migraines. This new product features a US FDA-approved composition, underscoring the company’s dedication to delivering high-quality healthcare solutions. Say Goodbye to Migraines with Vasograin EC: Cadila’s Latest Innovation, designed using enteric-coated (EC) technology, promises to transform the lives of

In the rapidly evolving landscape of healthcare, Fixed-Dose Combinations (FDCs) are emerging as a key strategy to address complex therapeutic needs. These combinations involve the formulation of two or more active pharmaceutical ingredients (APIs) in a single dosage form. This approach, while gaining momentum across the globe, especially in India, is being closely examined for

In the highly regulated pharmaceutical industry, product consistency, safety, and efficacy are essential pillars of quality assurance. One of the most critical aspects of ensuring this is validation—specifically, Process Validation and Product Validation. Though closely linked, these two concepts address different stages of pharmaceutical manufacturing. Understanding the Differences Between Process and Product Validation in Pharma

Sai Life Sciences, one of India’s fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMOs), has made a monumental stride in its mission to transform global pharmaceutical research. Sai Life Sciences Invests $150M in Cutting-Edge R&T Centre, recently unveiling its next-generation Research & Technology (R&T) Centre in Hyderabad. This milestone marks a significant leap forward in

Jynneos Vaccine Approved for Mpox Prevention in HIV Patients – this statement marks a significant turning point in the battle against Mpox, especially for immunocompromised populations. As the world continues to recover from the aftermath of COVID-19, attention is shifting towards other public health threats, such as Mpox (formerly known as Monkeypox), which has emerged